| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |